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CHAPTER I
INTRODUCTION
The aim of this project was to investigate the
possibility of utilizing the immune response of the
host to inhibit and/or eliminate oral malignancy.

Evi-

dence has shown that malignancies grow and spread often
with relatively little, or no demonstrable response by
the hosts immune system.

These responses may be due to

the tumor antigents lack of strength or inability of the
host's innate immune system to recognize the tumor antigen.

Another possible concept is that the host's an-

tibodies may cover tumor antigens present on cell surf aces thereby protecting the cancer cells from the cell

mediated immune response.

This would allow the cancer

cells to proliferate and/or metastasize.
In this study dimethylbenzanthracene, DMBA, was
used to induce a carcinomatous lesion in the hamster
cheek pouch.

Dinitrochlorobenzene, DNCB, was employed

to sensitize the buccal mucosa prior to, concomitantly
with, or after tumor induction of the hamster cheek pouch
in order to prevent, to eliminate or inhibit oral pouch
tumor development.
Leukoplakia has been recognized as the most common
1
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pre-cancerous lesion of the mouth.

The frequency of these

premalignant to malignant changes in the oral epithelium
can vary from 5 - 7% during an observation period of 3 20 years.

The hamster cheek pouch model has been suc-

cessfully used to study this lesion.
The induction of oral cancer in the pouch of the
hamster may be achieved by painting the pouch with DMBA
in mineral oil.
The progress of this disease begins with erythema, and ulceration followed by repair.

Increased mi-

totic activity, hyperkeratosis with acanthosis, papilloma and finally squamous cell carcinoma are the developmental stages of the lesion.
Practical clinical application of the results of
this study could result in sensitizing human leukoplakias
by topical application of DNCB or some other immune stimulant.

These drugs would immunotherapeutically eliminate

the lesion rather than committing the lesion to surgery
or risking a wait and watch policy.

CHAPTER II
STATEMENT OF PROBLEM
1.

T~

determine the correct concentration of DNCB

which will elicit an optimum cellular mediated response
in the hamster cheek pouch.
2.

Can DNCB, applied to a hamster pouch mucosa,

prevent the induction of tumors by DMBA?

Specifically,

can varying the time of application of DNCB during
tumor induction modify the numbers or sizes of the
tumors?

3

CHAPTER III
REVIEW OF THE LITERATURE
Since this project concerns itself with chemical
carcinogens, a brief review of the literature concerning
chemically induced tumors was necessary.
Yamigiwa and Ichikawa (1915) induced epithelial
malignancy in rabbit ears by cool tar application.
Tsutsin, with a similar solution, produced cancer of the
skin of mice.
Carcinogenic polycyclic hydro-carbons were described in the early 1930's by Kennaway and Huger.

The

first, discovered in 1930, was 1,2,5,6 dibenzanthracene, and soon after 3,4-benzpyrene was isolated; 20
methylcholanthrene, a very active carcinogen, was synthesized from bile acids.
Intensified studies have been done on these hydrocarbons; they have been called universal carcinogens
because they produce neoplastic disease by topical application, intramuscular and intravenous injection, or
by simple feedings

(Levy, 1963).

Levy and Ring produced sarcomas in hamsters by
subgingival implantation of crystalline 9,10-dimethyll,2-benzanthracine.

At four to five months, 80% of the
4
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animals had tumors (cited by Salley, 1954).

The effect

of a single topical application of 9,10-dimethyl-l,2benzanthracine on the skin and mucous membrane of mouse
lips was studied by Levy, Gorlin, and Gottzegen in 1950.
After 35 days, some premalignant changes were noted on
the labial mucous membrane.
Wantland studied the effect of spraying and
painting 20-methyl-cholanthrene, 1-2,5,6-dibenzanthracene, and 2-acetylaminofluorine on the hamster cheek
pouch.

After six weeks there were no changes other

than hyperplasia (Salley, 1954).
Salley (1954) undertook an intensive study to
determine the susceptibility of the hamster cheek pouch
to carcinogen application, and to find the most suitable carcinogen for this purpose.
month old hamsters were used.

Thirty-six three

The right pouch of each

hamster was painted three times a week for sixteen weeks
with a carcinogen with a #4 camel hair brush.

An addi-

tional nine weeks of observation followed this period
of painting.

Three carcinogens were used in various

combinations with two solvents.

These potent carcino-

gens were chosen on the basis of studies by Berenblum
and Iball (cited by Salley, 1954).

The above informa-

tion is best shown in the following study (Page 6).
Another group of animals was exposed to acetone

,
CARCINOGEN-SOLVENT STUDY
Series
A.

GrOUE_

I.

II.
III.

B.

IV.

v.
VI.

Carcinogen

Solvent

No. Animals

9,10-dimethyl-l,2benzanthracene (DMBA)

Acetone

3 Female
3 Male

20-methylcholanthrene

A·;etone

3 Female
3 Male

3,4-benzpyrene

Acetone

3 Female
3 Male

9,10-dimethyl-l,2benzanthracene

Benzene

3 Female
3 Male

20-methylcholanthrene

Benzene

3 Female
3 Male

3,4-benypyrene

Benzene

3 Female
3 Male

O'\
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and benzine applications to determine the effects of the
solvents listed in the preceding study.

Another group

was painted with physiologic saline to study any possible
traumatic effects of the brushing.
amined and weighed weekly.

The animals were ex-

After sacrificing the ani-

mals with chloroform, whole pouches were dissected out
and fixed with Bown's fluid.

After dehydration and em-

bedding, several sections were cut and stained with hematoxylin and eosin and Mallory's connective tissue stain.
Salley also sectioned cervical lymph nodes, tongue,
palate, eosophagus, fore stomach, stomach, lungs, and
liver.
The first tissue changes were noted in the group
using only benzene.

Acute inflammation with necroses

and sloughing were evident after two weeks.

Adhesions

had occurred in the pouch, reducing the normal three
to three and one-half centimeters pouch to one and onehalf centimeters.
hamsters of group

In this same period of time, six

B died;

control group also died.

two hamsters of the benzene
Survivors of these groups

healed with no recurrence of inflammation.
Microscopic examination revealed four levels of
change:

1) hyperplasia; 2) benign papilloma; 3) squa-

mous carcinoma in situ (pre-invasive); and 4) squamous
cell carcinoma with local invasion and metastasis.

The

,
8

following chart shows the results obtained (Page 9).
There were six original animals in each series.
Because of the high mortality rate, benzene proved unsatisfactory.

This is in agreement with Bradbury, Bachman,

and Lewisohn.

Bradbury, Bachman, Lewisohn, Stowal, and

Cramer also found acetone very satisfactory as a solvent.
It's free miscibility with water allows the carcinogen
to be transported into the cell with ease (Salley, 1954).
A glance at the following chart shows that 9,10dimethyl-l,2-benzanthracene (DMBA) in acetone is the
most potent, effective carcinogen.

Mineral oil replaced

acetone as a more effective vehicle which will be cited
further in this paper.

Later, Morris (1961) tested the

optimum concentrations of DMBA in the hamster pouch.
He found that 1.5% solution was extremely toxic and caused
a high percentage of mortality before initial lesions developed.

Even the survivors required the same length of

time to develop tumors as the 0.5% group.

Morris found

a 0.1% solution increased the latent period (period required to find some evidence of tumor), so that its use
was not practical.

Thus Morris found, as Salley did, that

0.5% was an optimum concentration of DMBA for producing
tumors.
Morris (1961) also used this same carcinogen and
painted animals both two and three times a week.

Three

1

r
ACETONE SERIES

Number
of
Survivors

Number
With
Benign
Tumors

Number
With
Carcinoma

Number
With
Metastasis

Time
of
Onset
(Weeks)

DMBA

5

0

5

5

7

20-Methylcholanthrene

5

2

2

0

25

3,4-Benzpyrene

5

1

2

2

16

BENZENE SERIES
DMBA

4

0

3

3

8

20-Methylcholanthrene

3

1

0

0

25

3,4-Benzpyrene

4

0

0

0

\.0
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times a week was found most satisfactory, as Salley had
previously

determined~

A shorter latent period was found

for the latter schedule.
Morris (1961) also studied the effect of age and
sex on hamsters receiving DMBA applications to the pouch.
Starting animals at three weeks, six weeks or. nine weeks
of age made no difference in response to the carcinogen.
Animals one year and a half, and older, phowed increased
resistance to tumor induction.

The sex of the specimen

had no influence on the final results.

In his experi-

ment, using 0.5% DMBA applied three times a week to the
hamster pouch, Morris obtained tumors in most animals
after 35 paintings or 12 weeks.

Morris tested the various

aspects of Salley's experiments and found a 0.5% carcinogen, concentration method of application, and a number
of applications to be optimal for tumor production in the
hamster cheek pouch.
In another study, Salley (1955) improved his
method for acquiring tumors in the hamster cheek pouch.
The acetone solvent was replaced by a nonvolatile mineral
oil (U.S.P. heavy) solvent.

This modification of solvent

decreased induction time with tri-weekly applications of
DMBA from 6 to 7 weeks (with acetone as a solvent) to
4 1/2 weeks.

Fifty weeks of mineral oil paintings, per

se, caused no carcinogenic activity.

'··· .. :.-_:
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Renstrup, et al.

(1962) demonstrated that chronic

mechanical irritation by use of producing ulceration in
the cheek pouch of the hamster increases the onset of cancer induced by DMBA.
Morris and Reisken {1965) showed that when the
hamster cheek pouch was exposed to tri-weekly applications
of DMBA for four weeks, all animals developed tumors in
a minimum amount of time.

Painting less frequently than

three times a week, failed to produce tumors in all animals in twenty-one weeks.
Elzay (1966) studied hamster pouches painted with
DMBA in alcohol and noted that clinically they developed
epithelial tumors earlier and larger than those painted
with DMBA in mineral oil.
Reisken and Berey (1968) showed that carcinomas
induced in the pouches of eight to twelve week-old hamsters by DMBA differed in behavior according to the host
strain.

The mean latent period in inbred dark-eared par-

tial albino (DEA) hamsters was 7.3 weeks, compared to
10.0 to 10.75 weeks in random-bred golden or cream hamsters.

The average tumor growth rate was significantly

higher in DEA animals than in the other two strains.
Duncan (1969) studied the relation of certain
hydrocarbons to metabolism and binding to cellular macromolecules.

He found that the potent carcinogens were to

12
bind DNA and RNA ten times more readily than non-carcinogens.
Immunotherapy
The demonstration of tumor· specific antigens in
human cancers was evidence that immunotherapy was an important mode of treatment.

Evidence accumulated suggested

that the cancer patient's immune response to these tumor
specific antigens was important in controlling the development and progression of their disease.

Those pa-

tients who can demonstrate an active immune system have
a better prognosis than those with general depression of
their immune reactivity.

These facts were cited by Hersh

in 1971.
Klein has shown that induction of delayed hypersensitivity reaction at tumor sites resulted in selective reactions against premalignant and malignant epidermal lesions which led to their eradication (1969).
Levis et al. showed 70% of basal cell carcinomas
treated with DNCB underwent complete regression (1973).
Klein believed the induction of delayed hypersensitivity reactions in tumor nodules or tumor tissues resulted in tumor regression in patients with basal or
squamous cell carcinomas of the skin.

Klein's initial

immunotherapeutic approaches were introduced to patients
with primary epidermal neoplasms.

These neoplasms included

13
multiple, extensive, premalignant epidermal lesions such
as keratosis of the surf ace epidermis and leukoplakia involving mucous surfaces and mucocutaneous structures.
Basal cell carcinomas, and squamous cell carcinomas, were
also studied.
The disappearance of locally invasive human cancer
following therapeutic imposition of a controlled allergic
contact dermatitis provided a useful model for the study
of immunotherapy of cancer.

This study applied the prin-

ciple of induced sensitivity and the induction of squamous cell carcinoma as a model employing the hamster cheek
pouch.

\

CHAPTER IV
MATERIALS AND METHODS
A.

Tumor Producing Agent
The carcinogen chosen for this study was 9,10 di-

methyl i,2, benzanthracene (DMBA).

This carcinqgen has been used by Salley and others to produce tumors in the hamster cheek pouch (Figure 1).

A #4

camel hair brush was used to paint a 0.5% solution of DMBA
in heavy mineral oil into the cheek pouch.
of DMBA in one application.

Dinitrochlorobenzene (DNCD)

14

There is 15 mg.

15
A yellow crystalline substance was used as a reagent for
the detection and determination of nicotinic acid, nicotinamide and other pyridine compounds; a powerful skin
irritant which resulted in a dermatitis.

Two pellets of

cotton containing the solution of DNCB were introduced
deeply into the pouch and left to remain until expelled

by the hamster, usually after ten minutes.

Each saturated

pellet of cotton contained approximately one ml. of DNCB
in acetone.

c.

Animals
Thirty-seven three month-old dark-eared albino

(DEA) hamsters were used.
rat chow and tap water.

The animals were fed Purina
Animal immobilization was accom-

plished by grasping the animals in a gloved hand and exposing the pouch by introducing a looped wire fastened
to a stand, into the corner of the mouth (Figure 2).
D.

Cell Mediated Response Determination
The objective was to.determine an optimum concen-

tration of DNCB which wouid elicit a cell mediated response without injury to the animal or pouch mucosa as
observed clinically.

Concentrations of 0.1%, 0.5%, 1 5),0'

5% and 10% DNCB in reagent grade acetone were administered to six hamsters.

Two pellets of cotton, each con-

taining 1 ml. of the various concentrations of DNCB were
introduced deeply into each pouch and left to remain until

..
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expelled by the hamster, usually after ten minutes
(Table I) •
Two hamsters received 0.1% solutions in their left
pouch and 0.5% solutions in their right pouch.

Two ham-

sters received 1% solutions in their left pouch and 5% solutions in their right pouch.

The last two hamsters re-

ceived a 10% solution in their left pouch and the right
pouch was used as a control.

Each hamster received the

sensitizing doses on days one and three and the mucosa
was challenged two weeks from the second sensitizing dose,
or day seventeen.

The challenging dose was one tenth the

concentration of each of the initial sensitizing doses.
One week of observation was allowed following the challenging dose for any reaction to occur.

At this time

the animals were sacrificed with a lethal dose of diethyl
ether.
This initial attempt failed in that the solutions
proved to be too concentrated.

One of the animals treated

with 10% DNCB died before· the sacrifice

day and others

showed frank ulcerations through the pouches to the external skin.

Other pouches with the exception of the lowest

concentrations showed large ulcerated areas (Figure 3).
A second series of dilutions of DNCB was employed
(Table II).

The new range of solutions were 0.1%, 0.5%,

.001%, .0005%, .00001%, .000005% of DNCB in acetone.

The

17
control solution was composed of pure reagent acetone.

The

seven concentrations were administered to fourteen hamsters
according to the following schedule.

On the first and

third days of the experiments, two hamsters received 0.1%
DNCB in each of four pouches.

The next two hamsters re-

ceived .05% DNCB in each of four pouches.

The following

two hamsters received a .001% DNCB in each of four pouches.
The following two hamsters received a .0005% DNCB in each
of four pouches.

The following two hamsters received a

.00001% DNCB in each of four pouches.

The following two

hamsters received a .000005% DNCB in each of four pouches.
The last two hamsters served as controls and received only
a solution of acetone in each of four pouches.

The ham-

sters were then allowed to rest for fourteen days.

At

this time each hamster received the challenging doses of
DNCB.

One week of observation for adverse tissue reac-

tion was again allowed following the challenging dose.

At

this time the hamsters were sacrificed with a lethal dose
of diethyl ether.
The pouches were removed from the hamsters in all
experimental groups, fixed in formation for twenty-four
hours, washed in tap water and then they were processed to
increasing concentrations of alcohol.

The concentrations

of alcohol were 65%, 70%, 80%, 95%, and 100%.

The pouches

were then transferred and cleared in xylene and then

18
embedded in liquid paraffin.

Paraffin blocks were made

and six micron sections were cut on a microtome and stained
with hematoxylin and eosin.
It was determined that the 0.1% concentration of
DNCB produced an optimum cell response characterized by
a lyrnphocytic infiltration in the lamina propria.

This

concentration was used to sensitize the mucosa in the following DNCB-DMBA hamster pouch tumor induction study.
E.

DNCB-DMBA Hamster Pouch Tumor Induction
The following is a schedule employed using DNCB

and DMBA in three separate experiments (Tables III A, B,
and C) •
Experiment I, Group A
This experiment employed three hamsters.

A 0.1%

DNCB concentration in acetone with approximately 1 ml. of
DNCB per pellet was administered to both pouches of three
hamsters on day one and day three.

Fourteen days later

the pouches were challenged with a .01% DNCB concentration
in acetone.

On day eighteen twice weekly concentrations

of 0.5% DMBA in mineral oil were administered by painting
with a #4 camel hair brush with approximately 15 mg. of
DMBA per application.

The twice weekly painting continued

for fourteen weeks at which time the animals were sacrificed (Table III A) •

''\
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Experiment II, Groups B, E, F, G, H
This experiment employed ten hamsters.

A 0.1% DNCB

concentration was administered to both pouches of ten hamsters on day one and day three and fourteen days later the
pouches were challenged with a .01% DNCB concentration.

On

day eighteen twice weekly paintings of 0.5% DMBA in mineral
oil were administered as in experiment I for fourteen
weeks.

At this time eight of the ten hamsters were re-

challenged with the .01% DNCB concentration; two hamsters
not challenged with DNCB were used as controls.

These two

hamsters received only the DNCB and DMBA as in experiment
I but no further challenge with DNCB.
One week after the first rechallenge two hamsters
were sacrificed.

The remaining six hamsters again were

rechallenged with a 0.01% DNCB solution applied to their
pouches.

One week later, two of the six remaining ham-

sters were sacrificed.

The remaining four hamsters were

again rechallenged with a 0.01% DNCB solution.
later two of the four hamsters were sacrificed.

One week
The re-

maining two hamsters again were rechallenged with a 0.01%
DNCB solution.

In the next and final week the last two

hamsters were sacrificed.

Also, the two control hamsters

were sacrificed at this time (Table III B).
Experiment III, Groups

c,

D

This experiment employed four hamsters.

Unlike

20
experiment I and II, experiment III begins with first inducing the tumor by twice weekly paintings with 0.5% DMBA
in mineral oil for fourteen weeks.

Then at this time,

three hamsters were treated with the predetermined sensitizing doses of 0.1% DNCB on day one, day three and a
challenging dose of .01% DNCB fourteen days later.

The

three hamsters were then sacrificed.
The fourth hamster was kept as a non-DNCB sensitized control and received only DMBA paintings for fourteen weeks and was then sacrificed.

Note:

no tumors

were counted clinically before or after DNCB administration (Table III C).
The pouches were removed from all sacrificed hamsters, fixed tn formalin for twenty-four hours.

They

were dehydrated in ascending alcohols, cleared in xylene
and embedded in paraffin.

Sections were cut at six mi-

crons and stained with hematoxylin and eosin.

The sec-

tions from all pouches were examined histologically and
the tumors were counted and described.

Measurements of

the tumor dimensions as seen on the histologic slide were
recorded.

Al~o,

using a reticular eyepiece containing a

50 micron square grid, the number of lymphocytes and plasma cells per fifty micron square field was averaged from
three randomly selected fields and recorded.

CHAPTER V
RESULTS
Experiment III, Group D (Table VI)
This was the control group in which one hamster received DMBA paintings only, for fourteen weeks.

Two ad-

vanced squamous cell carcinomas were seen, one in each
pouch (Figure 4).

The two tumors measured 450 microns by

250 microns and 400 microns by 300 microns, respectively.
All the classical characteristics of malignancy were present with hyperchromatism, frequent mitotic figures, cell
nests and papillary projections.

The cellular infiltrate

in the connective tissue confronting the tumors was
slight, an average of 12.2 lymphocytes per 50 microns

2

was

seen and an average of 0.66 plasma cells was seen per 50

.
2
microns •
Experiment III, Group C (Table VI)
This group represents three animals treated first
with DMBA and then treated with DNCB.
papillary tumors were seen (Figure 5).

Twelve non-invasive
The size of the

papillomas averaged 142 x 150 mm. apparently smaller than
in the pouches in the Experiment III, Group D control.
Four pouches were examined.

Four tumors of the papilloma

type were seen in one pouch, three tumors were observed in

21
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a second and third pouch, and two tumors were seen in a
fourth pouch.

In this group the cellular infiltrate ex-

hibited an average of SO lymphocytes/SO microns
plasma cells/SO microns

2

(Figure 6).

2

and 2.7

The lymphocytes were

seen invading the epithelium as well as the connective tissue confronting the tumor.

It was observed that some areas

which were non-tumor bearing showed ulceration of the epithelium and, also, exhibited a heavy infiltrate of lymphocytes into the lamina propria and epithelium (Figure 7).
Polymorphonuclear leukocytes were also accompanying the
lymphocytes and plasma cells {Figure 8) •
Experiment I, Group A {Table IV)
This group represents pretreatment with DNCB and
then treatment with DMBA.

A total of two non-invasive

papillary tumors were found in four pouches.

One tumor

was a carcinoma in situ which showed hyperplasia with
dyskeratosis, hyperchromatic cells, mitosis and acanthosis.
The other tumor was a papillary carcinoma showing similar
histologic characteristics.

Also, the non-tumor areas of

the pouch mucosa showed hyperkeratosis with acanthosis
(Figures 9 and 10).

The cellular infiltrate showed an

average of 20 lymphocytes/SO microns
50 microns

2

2

and .5 plasma cells/

as seen under a high power field.

This lympho-

cytic infiltrate was seen invading into the epithelium in
ulcerated non-tumor bearing areas (Figure 11).
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Experiment II, Groups B, E, F, G, H (Table V)
This group represents animals pretreated with DNCB
then treated with DMBA for fourteen weeks and then rechallenged with DNCB.

A total of five tumors of the papillary

carcinoma type as seen before in the other experiments were
found in twenty pouches.
mors.

Seventeen pouches showed no tu-

The tumors were papillary in nature and on the aver-

age measured 70 microns x 100 microns.

A few areas of hy-

perkeratosis with acanthosis were seen with an infiltration of lymphocytes into the lamina propria and epithelium
of non-tumor bearing areas (Figure 12).

Two control ani-

mals in Group H showed two squamous cell carcinomas in si t:u
measuring 300 microns x 400 microns.

These animals re-

ceived initial DNCB treatment and subsequent DMBA administration with no rechallenge of DNCB.~

CHAP'rER VI
DISCUSSION
The use of DNCB in hamster pouches to induce the
cell mediated response is positively effective.

However,

high concentrations of DNCB is injurious to the pouches
producing severe ulcerations.

DNCB dilutions of 0.1%

concentrations in acetone will induce an optimum cellular
response without noticeable tissue modification to the hamster pouch.

The demonstrated cell mediated response cor-

responds well to studies undertaken by Klein and Holterman
who showed induction of delayed hypersensitivity reactions
at tumor sites resulted in reactions against epidermal lesions which led to their eradication.

Also, Levis et al.

showed basal cell carcinomas treated with DNCB underwent
complete regression.

This study showed a cell mediated

response can be produced in the hamster pouch.

Therefore,

the concept that the hamster pouch is a privileged site,
as reported by Shepro, cannot be supported by this study.
Shepro

~

al. has pointed out the hamster pouch

is an "immunologically privileged site".
pu~ported
ce~t

It therefore is

to possess poor immunological ability.

This con-

was based on transplant studies in which skin grafts

showed a long survival time in cheek pouch compared to
24
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other parts of the body.

A lack of lymphotic drainage has

been reported to be the cause of the immunological privileged site.

However, Lindemann in 1968 did demonstrate the

presence of lymphocytic vessels in the cheek pouch of the
hamster.
The hamster pouches develop tumors when treated
with DNCB-DMBA.

However, .hamster pouch tumor induction

resulted in the greatest number of tumors when DMBA induction of tumors was followed by DNCB treatment.

This was

supported by the fact a total of twelve papilloma type
non-invasive tumors were seen in four hamster pouches using
this regimen.

When sensitization with DNCB occurred be-

fore the induction of tumors by DMBA, only two non-invasive
tumors were found in the four hamster pouches.

This treat-

ment schedule using DNCB prior to DMBA tumor induction appeared to be further effective when DNCB challenge of the
mucosa bearing tumors was again employed.

This became evi-

dent as only five non-invasive tumors were seen in twenty
pouches.
The hamster pouches treated with DMBA alone, showed
two invasive type squamous cell carcinomas in two pouches.
This would suggest DNCB did not alter tumor induction.
However, it is apparent in the presence of a cell mediated
response produced by DNCB administered either before or
after DMBA, tumors will form.

Treatment with DNCB prior to
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DMBA showed reduced tumor numbers.

It is significant that

invasive tumors were seen only in the DMBA control animal
while none was seen in the pouches treated with DNCB.
All of the tumors found in the pouches treated with
DNCB were of a smaller size than the tumors induced by DMBA
alone.
A lymphocytic and plasma cell mediated response was
seen in all DNCB treated groups.

In addition, the cell me-

diated response was greater than the pouches not treated
with DNCB.

In post-treated DNCB hamsters the cell mediated

response was greatest with an average count per 50 microns

2

in a high power field showing 50 lymphocytes and 2.7 plasma
cells.

This compares with the average count of 20 lympho-

cytes and .5 plasma cells in animals pretreated with DNCB.
In the hamster given DMBA and not sensitized with DNCB,
there also occurred a cell mediated response.
count was 12.2 lymphocytes/SO microns

r:o
.>

.
2.
microns

2

The average

and .66 plasma cells/

This suggested hamsters are capable of a cell

mediated response without DNCB.

Conversely, however, when

DNCB treatment was employed the cell mediated response was
clearly enhanced.
An important observation is the presence of lymphocytes seen not only in the lamina propria, but also invading the epithelium (Figure 7).

It may be significant

that the lymphocytes seen in the epithelium resulting from
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a cell mediated response are reacting to some tumor associated antigen.

To be effective, these lymphocytes must

contact the tumor cells in the epithelium to effect an antigen-lymphocyte response.

It was significant that a lym-

phocytic infiltrate was also observed in non-tumor bearing
areas of DMBA-DN'...:B treated mucosa.
ulcers were found.

In such areas micro-

It is a possibility such ulcers may

have resulted from a reaction between lymphocytes and epithelial cells containing tumor associated antigens.

Such

cells may have been part of a preexisting tumor destroyed
by the lymphocytes or a reaction with tumor associated antigens on epithelial cells which have undergone neoplastic
transformation.

Furthermore, the ulcer may have been the

result only of DNCB sensitized epithelial cells which were
lost as a result of a cell mediated response which occurred
upon challenge with DNCB.

This suggestion was supported

by the studies of Klein and Holterman and Levi who stated
tumor progress may be altered by sensitizations and challenge with DNCB.

Future studies with an increased number

of specimens should be performed to validate the results
of this pilot study.

CHAPTER VII
SUMMARY
Thirty-seven three month-old dark-eared albino hamsters were used to determine the capacity of the hamster
pouch to raise a cell mediated response.
It also was the intent of the study to determine
if DNCB sensitized mucosa either prevented tumor development, reduced tumor number or destroyed the tumor.
This investigation was divided into two sections.
The first section was to determine the dilution of DNCB
that could raise a cell mediated response without clinically destroying the animal or mucosa.

This was found to

be 0.1% DNCB in acetone.
The second section of the study consisted of three
experiments.
The first experiment employed three hamsters.

The

hamsters were pretreated with DNCB and then DMBA tumor induction was initiated.
The second experiment employed ten hamsters.

The

hamsters were pretreated with DNCB and then DMBA tumor initiation followed by weekly challenges with DNCB.
The third experiment employed four hamsters.

The

hamsters were administered DNCB initially followed by DNCB
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post-treatment.

A control hamster received only DMBA.

All

DMBA applications were 0.5% in mineral oil.
All of the animals treated with both DNCB and DMBA
developed tumors.

However, there was a reduction in tumor

size and no tumor invasiveness seen in animals treated with
DNCB when compared with animals not treated with DNCB.
The pouch treated with DNCB showed a cell mediated
response in all instances.
a tumor was present.

This was noted whether or not

This demonstrated the capacity of

DNCB to induce a cell mediated response.

CHAPTER VIII
CONCLUSION
Tumors were induced in hamster pouches with DMBA
alone or in combination with DNCB.
The mucosa of the hamster was capable of producing
a cell mediated response with a 0.1% DNCB concentration in
acetone.
There is suggestive evidence that the tumors induced in hamster pouches are smaller in size when the
pouches are treated with DNCB and DMBA than with DMBA
alone.
Hamster pouches which form tumors induced by DMBA
alone showed a cell mediated response although the number
of lymphocytes was less than when treated with DNCB.
DNCB enhanced the cell mediated response in hamster pouch tumors.
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FIGURE 1
DMBA INDUCED TUMOR IN HAMSTER CHEEK POUCH
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FIGURE 2
EXPOSING HA...\1STER CHEEK POUCH BY INTRODUCTION
OF LOOPED WIRE
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FIGURE 3
ULCERATED CHEEK POUCH TISSUE
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FIGURE 4
INVADING SQUAMOUS CELL CARCINOMA
Epithelial pearls.
Infiltrati n g nests of squamous
epithelial cells. X400 H.+E.
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FIGURE 5
PAPILLOMA
XlOO H.+E.
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FIGURE 6
PAPILLOMA WITH LY.MPIIOCY'l'E INFILTRATION

X250 H.+E.
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X400 H.+E.

X250 H.+E.
FIGURE 7
LYMPHOCYTES INVADING LAMINA PROPRIA IN ULCERATED AREA
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FIGURE 8
LAMINA PROPRIA HAMSTER POUCH SHOWING CAPILLARY
AND DEVELOPING PLASMA CELL

ELECTRON MICROGRAPH
Xl6800
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FIGURE 9
ACANTHOSIS WITH HYPERKERATOS I S AND
LYMPHOCYTIC INFILTRAT I ON
X250 H.+E.
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FIGURE 10
THICKENED EP I THELIUM WITH KERATIN PEELING OFF
X250 H.+E.
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XlOO H.+E.

FIGURE 11
ULCERATION WITH LYMPHOCYTIC INFILTRATION
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HYPERKERATOSIS WITH ACANTHOSlS
X250 H.+E.

HYPERKERATOSIS
X400 H.+E.
FIGURE 12

46

NORMAL HAMSTER POUCH EPITHELIUM
XlOO H.+E.
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TABLE I
DNCB CELL MEDIATED RESPONSE DETERMINATION
INITIAL SERIES
DAY 1 AND DAY 3 SENSITIZING DOSE
Hamster

0.1%

1

Left Pouch

Right Pouch

2

L.P.

R.P.

0.5%

1%

5%

3

. L. p •

R.P.

4

L.P.

R.P.

10%

5

L.P.

6

L.P.
Clinically
Normal

Clinically
Normal

·Necrotic

Necrotic

Necrotic

.i::.

.....i

...,
TABLE I continued
DAY 17 CHALLENGING DOSE
Hamster

.01%

.05%

1

L.P.

R.P.

2

L.P.

R.P.

.1%

0.5%

3

L.P.

R.P.

4

L.P.

R.P.

1%

5

L.P.

6

L.P.
Clinically
Normal

Necrotic

Necrotic

Necrotic

Animal
Died

.i::..

00

-~

TABLE II
DNCB CELL MEDIATED RESPONSE.DETERMINATION
SECOND SERIES
DAY l AND DAY 3 APPLICATIONS
Hamster

1
2
3

4
5
6
7
8

.000005%
LP
LP

.00001%

LP
LP

9

o
LP
RP

.001%

.05%

0.1%

Acetone

RP
RP

10
11
12
13
14

+

.0005%

= Optimum Response
= Failure of Response
= Control
= Left Pouch
= Right Pouch

RP
RP
LP
LP

RP
RP
LP
LP

RP
RP
LP
LP

RP

RP
LP
LP

RP
RP
LP 0 RPo
LPo RPo

.i:.
l.O

-.,
TABLE II continued
DAY 17 APPLICATION
Hamster
1
2
3

4
5
6

.0000005%

.000001%

= Control

.01%

Acetone

LP- RPLP- RPLP- RPLP- RP-

9

o

.005%

LP- RPLP- RP-

LP- RPLP- RP-

10
11
12
13
14

= Optimum
= Failure

.0001%

LP- RPLP- RP-

7
8

+

.00005%

LP+ RP+
LP+ RP+
f"

LPo RPo
LPo RPo

Response
of Response

lJ1
0

-...,
Tl\BLE III A
FLOWSHEET OF DNCB-DMBA EXPERIMENTS
Exp. I
Group A
Sensitization
With DNCB
Then DMBA
(3 Animals)

Day 1

Day 3

.1%
DNCB
Sensitizing
Dose

.1%
DNCB
Sensitizing
Dose

Day 17
.01%
Challenging
Dose

Day 18
DMBA

Sacrifice
Continue
Biweekly
Paintings
For
14 Weeks

U'1

.....

--------~--~==~~=~------~-~~

~

,.

TABLE III B
FLOWSHEET OF DNCB-DMBA EXPERIMENTS
Exp.

II

Sensitization
With DNCB
Then DMBA
and Subsequent
Re challenge
With DNCB
(10 Ani.mals)

Day 1
.1%
DNCB

Day 3 Day 1 7 Day 18
.1%
• 01%
DMBA.
Continue Biweekly
Paintings For
14 Weeks
Rechall.
8 Animals
.01%

2 Animals
Control
(No Rechall.)

1 Week

Group B

Sac. 2 An.
Rechall. 6 An.
1 Week

Group E

Sac. 2 An.
Rechall. 4 An.
1 Week

Group F

Sac. 2 An.
Rechall. 2 An.
1 Week

Group G

Sac. 2 An.
Last

Sacrifice
2 Controls
Group H

U1
I\)

---TABLE III C
FLOWSHEET OF DNCB-D.MBA EXPERIMENTS
Exp. III

DMBA Tumor
Production
Then
Sensitization
With DNCB
(4 Animals)

Day l
.1%
DNCB

Day 3
.1%
DNCB

Day 17
.01%
DNCB
Sac. Group C

3 Animals
~----------~------------,.-

14 Weeks
DMBA
Biweekly

~

~
p

Sac. Group D
1 Animal
Control

No DNCB

lJ1

w

'

-,
TABLE IV
DNCB-DMBA EXPERIMENT
Exp. I
Treatment
With DNCB
Followed
By DMBA
Tumor
Size
Group A
Pouch 1

µ

None

Other
Epithelial
Change

Lymphocyte
Count/SO µ2

Plasma Cell
Count/SO µ2

20

•5

"

II

"

II

"

II

II

"

1. Hyperplasia

None

2. Hyperplasia
With
Dyskeratosis
Pouch 2

Squamous
Ca. In Situ 50 X 200

Pouch 3

None

None

Pouch 4

Papilloma

40

x

120

None

01
~

...,
TABLE V
DNCB-DMBA EXPERIMENT
EXE· II
Treatment With
DNCB Followed
By DMBA And
Rechallenged
With DNCB

Group B
Pouch 1

Tumor
Size

Tumor
Type
None

Other
Epithelial
Changes

_µ_

None

Hyperplasia
With
Hyperkeratosis

Lymphocyte
Count/SO µ2

Plasma Cell
Count/50µ2

20

.5

"

"

Pouch 2

II

"

Pouch 3

II

"

II

II

"

Pouch 4

II

If

II

"

II

None

1.11
1.11

~

TABLE V continued

Grou~

Pouch 1

None

Lymphocytes
Count/50 µ2

Plasma Cell
Count/50 µ2

20

.5

II

II

II

II

II

II

II

II

Hyperplasia
With
Hyperkeratosis

"

"

µ

Hyperplasia
With
Hyperkeratosis

None

Pouch 2

II

II

Pouch 3

II

II

Pouch 4

Other
Epithelial
Changes

Tumor
Size

Tumor
Ty Ee

None

x

Papilloma

50

100

Pouch 1

None

None

Pouch 2

"

"

Hyperplasia

II

"

Pouch 3

II

II

None

"

II

Pouch 4

II

II

II

II

GrouE._.K

II

U1

°'

---,

-,

TABLE V continued
Tumor
Size

Tumor
Type

GrouI?....Q

Other
Epithelial
Changes

µ

Plasma Cell
Count/SO µ2

20

.5

Pouch 1

None

None

Pouch 2

Papilloma

100 X 175 None

II

"

Pouch 3

None

None

II

II

"

II

II

"

Pouch 4

II

II

Hyperplasia

Lymphocyte
Co't1n t/50 µ 2

GrouE....!:!.
Pouch 1

Squamous
Cell Ca.
In Situ

300 X 400 Hyperplasia

II

"

Squamous
Cell Ca.
In Situ

300 X 400 Hyperplasia

II

"

None

None

None

"

"

II

II

---

--Pouch 2
Pouch 3

II

II

Hyperplasia

Pouch 4

II

II

None
U'1
.....i

--,

TABLE VI
DNCB-DMBA EXPERIMENT
Exp. III

DMBA Tumor
Production
Then DNCB
Treatment
Tumor
Size
µ

Tumor
Group C
Pouch 1

Pouch 2

~

Papilloma

135

x

135

II

40

x

80

II

60

x

60

II

60

x

60

II

135

x

150

II

110

x

110

II

150

x

200

Other
Epithelial
Changes
Ulcer
II

Lympohcyte
co·unt/50 µ2

Plasma Cell
Count/SO ·µ2

50

2.7

"

II

II

II

II

II

Ulcer

"

II

None

II

II

II

II

None
II

II

(Jl

co

...,

TABLE VI continued

Tumor
~
Pouch 3

Papilloma

Tumor
Size

Other
Epithelial
Changes

)l

100

Papilloma
300
Or Carcinoma
In Situ

x
x

150

Hyperplasia

200

None

Lymphocyte
Count/50 µ2

Plasma Cell
Count/50 µ2

50

2.7

"

II

"

II

Hyperplasia

II

"

None

II

II

---

Papilloma
Pouch 4

II

II

x 75
so x 50
50 x 80

150

II

Grou12 D
(Control)
Pouch 1

Invasive
Carcinoma

450

x

250

None

Pouch 2

Invasive
Carcinoma

400

x

300

"

12.2
II

.66

"
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